Related Experiment Video
Updated: Jul 9, 2026

07:02
Assessment of Chemical Toxicity in Adult Drosophila Melanogaster
Published on: March 24, 2023
Modeling and assaying dioxin-like biological effects for both dioxin-like and certain non-dioxin-like compounds
Jon G Wilkes1, Bruce S Hass, Dan A Buzatu
1Division of Systems Toxicology, Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock 72205-7199, USA. jone.wilkes@fda.hhs.gov
Summary
Quantitative Structure-Activity Relationship (QSDAR) models predict dioxin-like toxicity for polychlorinated dibenzodioxins, dibenzofurans, and biphenyls. This approach aids in identifying potentially toxic compounds for risk assessment and drug development.
Area of Science:
- Environmental Chemistry
- Toxicology
- Computational Chemistry
Background:
- Polychlorinated dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and biphenyls (PCBs) exhibit varying degrees of toxicity, often assessed using Toxic Equivalency Factors (TEFs).
- Accurate TEF assignment is crucial for risk assessment of contaminated sites and food, but many congeners lack defined TEFs.
- Existing methods for determining toxicity can be time-consuming and resource-intensive.
Purpose of the Study:
- To develop and validate Quantitative Spectrometric Data-Activity Relationship (QSDAR) models for predicting TEFs and Relative Potency (REP) values.
- To assess the potential dioxin-like toxicity of congeners with assumed zero TEFs.
- To explore the utility of QSDAR models combined with in vitro assays for efficient screening of chemical toxicity.
Main Methods:
- Correlated 13C NMR data with established TEFs for 29 PCDD, PCDF, and PCB congeners to build QSDAR models.
- Predicted TEFs and REPs for specific congeners, including 1,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and 1,2,3,4,7-pentachlorodibenzo-p-dioxin (PeCDD).
- Validated QSDAR predictions using an independent in vitro luciferase gene expression assay in mouse liver cells.
Main Results:
- QSDAR models predicted significant dioxin-like toxicity for TCDD (TEF=0.037, REP=0.115) and PeCDD (TEF=0.004, REP=0.020), challenging their assumed zero TEFs.
- In vitro assays confirmed these findings, yielding REPs of 0.027 for TCDD and 0.013 for PeCDD, showing good agreement with QSDAR predictions.
- The models were applied to predict activity for 108 additional congeners and a dioxin analog, demonstrating broad applicability.
Conclusions:
- QSDAR models, coupled with in vitro assays, offer a powerful and cost-effective approach for predicting dioxin-like toxicity and identifying compounds for further investigation.
- Risk assessments may underestimate toxicity if congeners with non-zero toxicity are incorrectly assigned zero TEFs.
- In silico and in vitro nomination protocols can streamline practical risk assessment for complex mixtures of chemicals with varying toxicities via a common mechanism.
Related Concept Videos
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

